Patents Assigned to Mazal Pharmaceutique (SARL)
  • Patent number: 6124358
    Abstract: Provided is a pharmaceutical composition based on rhein or diacerhein. The composition is intended for administration by the oral, rectal or cutaneous (percutaneous or transdermal) route, and comprises rhein or diacerhein, or one of their pharmaceutically acceptable salts or esters, and sodium lauryl sulfate, comicronized, in a weight ratio between 3:1 and 30:1. The composition exhibits improved bioavailability.
    Type: Grant
    Filed: August 20, 1998
    Date of Patent: September 26, 2000
    Assignee: Mazal Pharmaceutique (SARL)
    Inventors: Cyril Estanove, Alain Prudhomme